UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
AbClon, C&R Research sign CRO contract
AbClon said Thursday that it has signed a contract research organization (C...
by Lee Han-soo
|
2019-03-21 17:17
라인
2 drugs for enlarged prostate not different in depression risk
Two classes of the drug for enlarged prostate -- 5-alpha reductase inhibito...
by Lee Hye-seon
|
2019-03-21 16:51
라인
SK Biopharmaceutical’s US partner gets FDA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo
|
2019-03-21 15:26
라인
LG Chem licenses in PDC line’s anti-cancer vaccine
LG Chem said Thursday that it has signed a technology transfer agreement wi...
by Lee Han-soo
|
2019-03-21 11:17
라인
UK regulator OKs P1 trials of Shin Poong’s thrombotic disease treatment
Shin Poong Pharmaceutical said Tuesday that the U.K. Medicines and Healthca...
by Jeong Sae-im
|
2019-03-20 16:22
라인
Medytox launches 3rd BTX product
Medytox said Wednesday that it has launched Coretox, a pure botulinum toxin...
by Lee Han-soo
|
2019-03-20 11:29
라인
Novo Nordisk Korea unveils diabetes drug Fiasp in Korea
Novo Nordisk Korea celebrated the launch of Fiasp, its rapid-acting mealtim...
by Lee Han-soo
|
2019-03-19 17:37
라인
‘Bladder cancer treatment OncoTICE not out of stock’
The Ministry of Food and Drug Safety urgently notified that OncoTICE inject...
by Lee Hye-seon
|
2019-03-19 14:44
라인
Il-yang, Hanmi achieve robust sales growth in China
Two Korean pharmaceutical firms -- Il-yang Pharmaceutical and Hanmi Pharmac...
by Jeong Sae-im
|
2019-03-19 11:21
라인
Macrogen, Microba to cooperate on microbiome research
Macrogen said Monday that it has signed a memorandum of understanding with ...
by Lee Han-soo
|
2019-03-19 11:14
라인
Daewoong wins right to sell TerahVax’s typhoid fever vaccine
Daewoong Pharmaceutical said Tuesday that it plans to launch TerahVax Korea...
by Lee Han-soo
|
2019-03-19 11:14
라인
Hanmi, Santen sign co-promotion accord for dry eye treatments
Hanmi Pharmaceutical said Monday that it has signed a co-promotion agreemen...
by Lee Han-soo
|
2019-03-18 17:46
라인
Dong-A ST to market Suganon in India
Dong-A ST said Monday that it would start marketing Suganon, an independent...
by Lee Han-soo
|
2019-03-18 15:03
라인
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’
Apparently mindful of a rival botulinum toxin scheduled to be released in t...
by Jeong Sae-im
|
2019-03-18 15:03
라인
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resc...
by Lee Han-soo
|
2019-03-18 14:23
라인
Reimbursement for orphan drug Spinraza imminent
Biogen’s Spinraza (ingredient: nusinersen), a treatment for spinal muscular...
by Kim Yun-mi
|
2019-03-18 12:02
라인
Handok gets shares in TRIGR Therapeutics
Handok said Monday that it has invested $5 million to acquire shares in TRI...
by Lee Han-soo
|
2019-03-18 12:02
라인
Korean patients lack knowledge about risk of resistance development by BTX
More than half of the people who have undergone botulinum toxin (BTX) treat...
by Lee Han-soo
|
2019-03-15 15:39
라인
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors
The Ministry of Health and Welfare has ordered the suspension of reimbursem...
by Kwak Sung-sun
|
2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support
Theragen ETEX said Friday that the Korea Drug Development Fund (KDDF) would...
by Lee Han-soo
|
2019-03-15 13:21
-
이전
51
52
53
54
55
56
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top